Podlesak Dennis
SEC CIK 1314595 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | Dir | 239.8K | — | $2.77M | 10 | 2021-10-05 | 2026-02-04 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-04 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | A - Grant | $0.00 | +48.0K | 239.8K | +25% | $0 | |
| DMT | 2025-08-18 | 2025-08-14+ | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | S - Sale+OE | $15.19 | -57.6K | 191.8K | -23% | -$874.9K |
| DMT | 2025-08-18 | 2025-08-14+ | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | M - OptEx | $7.20 | +57.6K | 211.0K | +38% | +$414.7K |
| 2025-02-07 | 2025-02-05 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | A - Grant | $0.00 | +50.0K | 191.8K | +35% | $0 | |
| 2024-02-09 | 2024-02-07 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | A - Grant | $0.00 | +34.0K | 141.8K | +32% | $0 | |
| 2023-02-03 | 2023-02-02 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | A - Grant | $0.00 | +32.0K | 107.8K | +42% | $0 | |
| DM | 2022-09-16 | 2022-09-15+ | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | S - Sale+OE | $24.08 | -78.8K | 75.8K | -51% | -$1.90M |
| DM | 2022-09-16 | 2022-09-15+ | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | M - OptEx | $6.32 | +78.8K | 81.2K | +3,330% | +$498.3K |
| 2022-02-03 | 2022-02-02 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | A - Grant | $0.00 | +32.0K | 75.8K | +73% | $0 | |
| 2021-10-06 | 2021-10-05 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | J - Other | $0.00 | +463 | 43.8K | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations